Newswire and Healthcare Information

Pharmos Receives Milestone Payment From Bausch & Lomb for Zylet™ Commercial Launch

Iselin NJ, January 25, 2005 – Pharmos Corporation (Nasdaq: PARS) announced today that the Company has received a gross milestone payment of $12.1 million from Bausch & Lomb (NYSE: BOL), its former marketing partner for ophthalmology products. The milestone payment was triggered by Bausch & Lomb’s commercial launch of Zylet™, which was approved for marketing by the FDA on December 15, 2004. Zylet is part of […]